<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02720939</url>
  </required_header>
  <id_info>
    <org_study_id>201507086RINA</org_study_id>
    <nct_id>NCT02720939</nct_id>
  </id_info>
  <brief_title>ASD-specific Induced Pluripotent Stem Cells for Disease Modeling</brief_title>
  <official_title>ASD-specific Induced Pluripotent Stem Cells for Disease Modeling</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>National Taiwan University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Taiwan University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Specific Aims:&#xD;
&#xD;
        1. To generate induced-pluripotent stem cells (iPSCs) from peripheral blood mononuclear&#xD;
           cells (PBMCs) isolated from whole blood of ASD probands and healthy controls.&#xD;
&#xD;
        2. To derive neural progenitor cells (NPCs) and neurons from iPSCs of ASD probands and&#xD;
           healthy controls and compare differences between patients and healthy controls to&#xD;
           investigate the cellular phenotype of ASD and uncover the pathophysiology of the&#xD;
           disease.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Autism spectrum disorders (ASDs) is a common, lifelong impairing childhood-onset&#xD;
      neurodevelopmental disorder with clinical and genetic heterogeneity. The etiology of ASD is&#xD;
      complicated and remains largely unknown. Evidences indicate the high heritability (54-77%) in&#xD;
      ASD, and researchers also found copy number variations (CNVs) play an important role in the&#xD;
      etiology of ASD. However, due to the ethical issue, researchers haven't had an appropriate&#xD;
      platform to investigate the copy number change effect to date. In the following study,&#xD;
      researchers are going to derive ASD-specific induced pluripotent stem cells and neurons for&#xD;
      disease modeling.&#xD;
&#xD;
      10 ASD patients and 10 healthy controls will be included in the present study and iPSCs and&#xD;
      neurons will be generated from their PBMCs. Electrophysiological recording and analysis of&#xD;
      neuronal morphology will be conducted to reveal the cellular phenotype of ASD after comparing&#xD;
      differences between patients and healthy controls.&#xD;
&#xD;
      The study will provide a platform to reveal the etiology of genetic basis and molecular&#xD;
      mechanism of ASD. The cellular phenotype of ASD will be revealed by comparing differences&#xD;
      between patients and healthy controls. The findings from this work are expected to contribute&#xD;
      to the basic and clinical research on ASD.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">January 1, 2016</start_date>
  <completion_date type="Actual">December 31, 2016</completion_date>
  <primary_completion_date type="Actual">December 31, 2016</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>iPSC derivation and characterization</measure>
    <time_frame>12 weeks</time_frame>
    <description>To generate induced-pluripotent stem cells (iPSCs) from peripheral blood mononuclear cells (PBMCs) isolated from whole blood of ASD probands and healthy controls</description>
  </primary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">20</enrollment>
  <condition>Autism Spectrum Disorder</condition>
  <arm_group>
    <arm_group_label>ASD group</arm_group_label>
    <description>ASD patients who met the diagnostic criteria of either autistic disorder or Asperger's disorder defined by the DSM-IV criteria</description>
  </arm_group>
  <arm_group>
    <arm_group_label>TD group</arm_group_label>
    <description>Typically development controls without lifetime diagnosis with ASD or any psychiatric disorders</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Peripheral blood will be collected in the INSEPACK Disposable Vacuum Venous Blood Specimen&#xD;
      collection Tube (Green Tube with li-Heparin) and each tube will contain 5-10ml of blood from&#xD;
      ASD probands and healthy controls.&#xD;
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        The sample will consist of 10 ASD patients and 10 healthy controls.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  ASD group: Subjects who met the diagnostic criteria of either autistic disorder or&#xD;
             Asperger's disorder defined by the DSM-IV criteria.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  TD group: Subjects with any current or lifetime DSM-IV psychiatric disorders.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Susan Shur-Fen Gau, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>National Taiwan University Hospital &amp; College of Medicine</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>National Taiwan Univeristy Hospital</name>
      <address>
        <city>Taipei</city>
        <country>Taiwan</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Taiwan</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>March 22, 2016</study_first_submitted>
  <study_first_submitted_qc>March 25, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 28, 2016</study_first_posted>
  <last_update_submitted>September 1, 2021</last_update_submitted>
  <last_update_submitted_qc>September 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 2, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Autism Spectrum Disorder</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

